Back to AVXL
VANGUARD GROUP INC AVXL Position History
Anavex Life Sciences Corp. • Healthcare
Quarters held
20
Latest value
$67K
Q4 2025
Peak value
$45.3M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $363K |
| Q1 2025 | $453K |
| Q1 2025 | $40.8M |
| Q1 2025 | $322K |
| Q1 2025 | $162K |
| Q2 2025 | $750K |
| Q2 2025 | $486K |
| Q2 2025 | $45.3M |
| Q2 2025 | $388K |
| Q2 2025 | $174K |
| Q3 2025 | $4.9M |
| Q3 2025 | $39.5M |
| Q3 2025 | $168K |
| Q3 2025 | $374K |
| Q3 2025 | $470K |
| Q4 2025 | $2.1M |
| Q4 2025 | $188K |
| Q4 2025 | $15.4M |
| Q4 2025 | $121K |
| Q4 2025 | $67K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $67K | 18.8K | — | — |
| Q4 2025 | $121K | 34.1K | — | — |
| Q4 2025 | $15.4M | 4.33M | — | — |
| Q4 2025 | $188K | 52.8K | — | — |
| Q4 2025 | $2.1M | 591.8K | — | — |
| Q3 2025 | $470K | 52.8K | — | — |
| Q3 2025 | $374K | 42.1K | — | — |
| Q3 2025 | $168K | 18.8K | — | — |
| Q3 2025 | $39.5M | 4.44M | — | — |
| Q3 2025 | $4.9M | 554.2K | — | — |
| Q2 2025 | $174K | 18.8K | — | — |
| Q2 2025 | $388K | 42.1K | — | — |
| Q2 2025 | $45.3M | 4.91M | — | — |
| Q2 2025 | $486K | 52.8K | — | — |
| Q2 2025 | $750K | 81.3K | — | — |
| Q1 2025 | $162K | 18.8K | — | — |
| Q1 2025 | $322K | 37.6K | — | — |
| Q1 2025 | $40.8M | 4.75M | — | — |
| Q1 2025 | $453K | 52.8K | — | — |
| Q1 2025 | $363K | 42.3K | — | — |
Other funds holding AVXL
$37.2M
$34.2M
$33.9M
$29.3M
$27.6M
$27.2M
$25.9M